Literature DB >> 29122357

Kidney Injury Molecule-1 Level is Associated with the Severity of Renal Interstitial Injury and Prognosis in Adult Henoch-Schönlein Purpura Nephritis.

Yuanyuan Zhang1, Aiju Li2, Jiliang Wen3, Junhui Zhen4, Qiufa Hao1, Yidan Zhang1, Zhao Hu1, Xiaoyan Xiao5.   

Abstract

BACKGROUND AND AIMS: Kidney injury molecule-1 (KIM-1) was identified the most highly upregulated protein in chronic kidney diseases and prolonged KIM-1 expression may be maladaptive. The present study was aimed to investigate urinary, renal and plasma KIM-1 levels and to analyze association between KIM-1 levels with clinical and pathological indexes in adult Henoch-Schönlein purpura (HSP) patients.
METHODS: Twenty healthy individuals, 20 HSP patients without nephritis and 35 HSP patients with nephritis were recruited. Urinary and plasma KIM-1 levels were determined by ELISA and Luminex, respectively. Renal KIM-1 expression was evaluated by immunohistochemistry.
RESULTS: HSP patients with nephritis were characterized as elevated levels of urinary, renal and plasma KIM-1. Those with more severe tubular injury of renal biopsy tissues presented significantly higher urinary and renal KIM-1 levels compared to control and patients without nephritis. Urinary and renal levels of KIM-1 were positively correlated with blood urea nitrogen and proteinuria, while they were negatively correlated with eGFR at both baseline and after two years follow-up. Moreover, plasma KIM-1 levels were associated with blood urea nitrogen and proteinuria as well. Further univariate correlation analysis indicated urinary and renal KIM-1 levels were positively correlated with interstitial inflammation index and tubulointerstitial chronicity index. Only urinary KIM-1 levels were associated with interstitial inflammation index, tubulointerstitial chronicity index and extracapillary glomerular activity index, after logistic regression analysis. The area under the curve (AUC) for urinary KIM-1/Cr predicting progression of renal damage was significantly greater than the AUC for proteinuria.
CONCLUSIONS: This finding suggests that measurement of urinary and renal KIM-1 level may be helpful to evaluate severity of renal pathological damage and prognosis in adult HSP patients with nephritis.
Copyright © 2017 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular/fibrocellular crescents; Henoch-Schönlein purpura nephritis (HSPN); Kidney injury molecules-1 (KIM-1); Tubulointerstitial damage

Mesh:

Substances:

Year:  2017        PMID: 29122357     DOI: 10.1016/j.arcmed.2017.10.005

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  5 in total

1.  Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis.

Authors:  Wenjia Zhang; Zhongqiao Qin; Kecong Xian; Shuhong Tang
Journal:  J Int Med Res       Date:  2019-12-18       Impact factor: 1.671

2.  Analysis of mRNA and protein kidney injury Molecule-1 (KIM-1) expression in a kidney model during the initiation phase of ischemia reperfusion injury.

Authors:  Jerny Dase; Haerani Rasyid; Rina Masadah; Muhammad Husni Cangara; Agussalim Bukhari; Ressy Dwiyanti; Mochammad Hatta
Journal:  Ann Med Surg (Lond)       Date:  2022-02-11

3.  RUMA and RUPCR in children with Henoch-Schonlein purpura.

Authors:  Xiucui Han; Pengfei Xu
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 3.124

4.  Kidney Injury Molecule-1 and Periostin Urinary Excretion and Tissue Expression Levels and Association with Glomerular Disease Outcomes.

Authors:  Qiaoyan Wu; Jonathan P Troost; Tiane Dai; Cynthia Nast; Sean Eddy; Boxian Wei; Ying Wang; Debbie S Gipson; Katherine M Dell; Keisha L Gibson; Matthias Kretzler; Sharon Adler
Journal:  Glomerular Dis       Date:  2021-03-30

5.  A systematic review of urine biomarkers in children with IgA vasculitis nephritis.

Authors:  Chloe E C Williams; Aileen Toner; Rachael D Wright; Louise Oni
Journal:  Pediatr Nephrol       Date:  2021-05-15       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.